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Introduction: Sexual dysfunctions (SDs) have been frequently reported among male partners of infertile couples
due to psychogenic, relational and/or organic issues related with the inability to conceive. Likewise, male infertil-
ity (MI) could be a consequence of sexual dysfunctions.
Aim: To review the evidence on the prevalence and treatment of male SDs in men of infertile couples and pro-
vide clinical recommendations on behalf of the European Society of Sexual Medicine (ESSM).
Methods: The MEDLINE database was searched in September 2019 for randomized clinical trials (RCTs),
meta-analyses and open-label prospective or retrospective studies investigating the presence of erectile dysfunction
(ED) and/or ejaculatory dysfunctions (EjDs) and/or low sexual desire (LSD) in conjunction with infertility.
Main Outcome Measure: The panel provided statements on: (i) Prevalence and association between SDs and
MI; (ii) Treatment of male SDs in men of infertile couples.
Results: ED has been reported in 9% to 62% of male partners of infertile couples, with severe impairment
observed in only 1% to 3% of ED cases. Moreover, worse semen parameters have been associated with greater
ED severity. Phosphodiesterase type 5 inhibitors (PDE5is) can be safely used to treat ED among patients seeking
fatherhood. Male partners of infertile couples are at higher risk of premature ejaculation (PE). Retrograde ejacula-
tion (RE) and anejaculation are a cause of MI and can be managed with electroejaculation (EEJ) or penile vibra-
tory stimulation (PVS) or, alternatively, with oral treatments, however the latter with limited documented
success. Low sexual desire has been reported by one third of men of infertile couples.
Conclusion: ED could significantly affect male partners of infertile couple; PDE5is should be suggested to
ensure an effective and satisfactory sexual relationship of the couple. Anejaculation and RE should be considered
as a possible cause of MI and treated accordingly. Low sexual desire is frequently reported among men of infertile
couple and could be a symptom of other systemic conditions or psychological distress. Capogrosso P, Jensen
CFS, Rastrelli G, et al. Male Sexual Dysfunctions in the Infertile Couple−Recommendations From the
European Society of Sexual Medicine (ESSM). Sex Med 2021;9:100377.
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2 Capogrosso et alINTRODUCTION
Couple infertility is defined as the inability to conceive after
12 months of regular sexual intercourse.1 Population based stud-
ies have reported that about 15% of couples may suffer from
infertility, thus representing a considerable issue for the global
health community.2−4 In this context, approximately 40% to
50% of infertile couples are unable to conceive as a consequence
of male reproductive impairment.2−4
Sexual dysfunctions (SDs) affect a large proportion of men
with a detrimental impact upon subjective quality of life
(QoL)5,6 Epidemiological data suggest that about 50% of the
male population report at least one SD during their lifetime.7
Dysfunctions may involve several aspects of sexuality, including
sexual desire, erectile function (EF), ejaculation and orgasm.
Recently, a comprehensive review reported several studies evalu-
ating the association between male infertility (MI) and SDs.8 The
link between these conditions is essentially bi-directional: on one
hand patients suffering from fertility issues are commonly strug-
gling with feelings of depression and anxiety, which could affect
both the male and female partner, with a detrimental impact on
sexuality.8 Specifically, psychogenic erectile dysfunction (ED) and
low sexual desire (LSD) may be the consequence of a stressful sex-
ual context engendered by the inability to conceive.9 Likewise pre-
mature ejaculation (PE) could be the consequence of increased
anxiety in the male partner.5,9 On the other hand, some severe
SDs could significantly affect male reproductive function and have
been recognized as the cause of MI in a range between 0.4% and
4.6% of cases.8 Ejaculatory dysfunctions (EjDs), thus including
retrograde ejaculation (RE) and anejaculation, for instance, have
been shown to represent the main cause of MI in 1.2% and 2.2%
of cases.10 At the same time severe ED could impair fertility by
reducing the frequency of vaginal intercourses.11
Given the mutual association between MI and SDs, we aimed
to review the evidence on SDs and MI and to provide official
position statements regarding the prevalence and management of
SDs among patients with MI on behalf of the European Society
of Sexual Medicine (ESSM).EVIDENCE ACQUISITION
Literature Search and Study Eligibility
We searched MEDLINE using the terms: (“erectile dysfunc-
tion” OR “impotence” AND “infertility” OR “infertile” OR
“subfertile” OR ”azoospermia”) for ED; (“ejaculation” AND
“premature” OR “retrograde” OR “anejaculation” AND “infer-
tility” OR “infertile” OR “subfertile” OR “azoospermia”) for
EjDs; (“desire” OR “libido” AND “hypoactive” OR “low” AND
“male” OR “men” AND “infertility” OR “infertile” OR “subfer-
tile” OR “azoospermia”) for LSD. Randomized clinical trials
(RCTs), meta-analyses and open-label prospective or retrospec-
tive studies investigating the prevalence and treatment of ED,
EJDs and LSD among patients suffering from couple infertility(up to September 2019) were included. The research diagram is
reported in Figure 1.Data Extraction
Studies were categorized according to the specific fields of inves-
tigation (e.g. ED, EJDs or LSDs). Data regarding study design,
population baseline characteristics, prevalence of SDs, and modality
of SDs assessment were collected. Moreover, the estimates of the
association between SDs and MI or semen parameters were
recorded. For studies reporting management of male SDs among
infertile couples, data on treatment protocols and improvement of
specific outcomes related to each SDs were considered.Review Methods
Abstracts were reviewed by three different subgroups of the
panel for relevance to the defined review question (ED: PC, JT,
GIR; EjD: CFS; AF; LSD: GR, AR). If it was not clear from the
abstract whether the paper might contain relevant data, the full
paper was assessed. Moreover, other studies relevant to the
research question were retrieved from the reference lists of
selected papers. Included studies were analysed and summarized
after an interactive peer-review process of the panel. Clinical
statements were provided for: (i) Prevalence and association
between SDs and MI; (ii) Treatment of male SDs in patients suf-
fering from couple infertility. The statements were internally dis-
cussed and the level of evidence (LoE) was provided according to
the Oxford 2011 Levels of Evidence criteria; moreover, the qual-
ity of evidence was graded by applying the Oxford Centre for
Evidence-Based Medicine recommendations (https://www.
cebm.net/2011/06/2011-oxford-cebm-levels-evidence-introduc
tory-document/);. No recommendations were given when the
available data were insufficient to draw conclusions. Disagree-
ments were resolved by consensus.
No ethical committee approval was needed due to the specific
design of this research.
ERECTILE DYSFUNCTION
Statements
1 Prevalence and association
 Male partners of infertile couples are at higher risk of reporting
ED (Level 3; Grade C)
 Worse seminal profile is associated with more severe ED (Level
3; grade C)
2 Treatment
 Phosphodiesterase type 5 inhibitors (PDE5is) can be safely admin-
istered to infertile men suffering from ED (Level 1; grade B)
 Further studies are needed to investigate the possible effect of
PDE5is in terms of sperm parametersEvidence
1. Prevalence and associationSex Med 2021;9:100377
Figure 1. Flow charts showing inclusion and exclusions criteria of articles for the review.
Male Sexual Dysfunctions from ESSM 3The first report on ED and infertility was published by Berger
et al in 1980.12 They reported at least temporary ED in 10 out of
16 azoospermic men. In 1986 Chelo et al13 interviewed 61 men
of infertile couples finding that 42% of them thought that “peo-
ple” consider the lack of children as related to male impotence.
After these preliminary studies, we identified, 8 case-control stud-
ies14−21 and 14 cross-sectional single arm studies5,22−34 investigat-
ing the association between ED and infertility (Table 1).
Furthermore, the association has been addressed in a RCT by
Coward et al.,35 investigating ovarian stimulation before intrauter-
ine insemination. The vast majority of these studies applied the
validated International Index of Erectile Function (IIEF) question-
naire to investigate ED, reporting a prevalence of EF impairment
ranging from 9% to 62%, being mild to moderate in most of the
cases with severe ED in only 1% to 3% of patients (Table 1).
In a secondary analysis of the RCT by Coward et al.,35 the
authors looked at ED in men of couples with unexplainedSex Med 2021;9:100377infertility. Out of 708 men, ED was found in 9% of cases as
assessed with the IIEF. They reported that lower fertility related
quality of life was associated with higher risk of ED (OR:1.3;
95%CI: 1.16 - 1.46). It should be noticed that ED assessment
was not the primary outcome of this trial. In a case-control study,
Gao et al.19 compared 1468 infertile men and 942 fertile con-
trols, reporting a higher prevalence of ED (IIEF-5 score < 22) in
the infertile group (18.05% vs 8.28%, P < .001). Similarly, Lotti
et al17 compared 448 men of infertile couples and 74 age-
matched fertile men. They reported higher prevalence of ED
(IIEF-EF score < 26) in infertile males compared with controls
(18.3 vs 0%, P = .006). Interestingly, IIEF scores decreased as a
function of severity of semen quality impairment. Similar results
were reported in a three-group study comparing azoospermic
men, men with a sperm count < 15 mil/ml and men with sperm
count > 15 mil/ml.15 The direct correlation between semen
quality and EF could be the consequence of an adverse emotional
reaction to severe seminal abnormalities; however, it could be
Table 1. Studies assessing ED among male partners of infertile couples
Study Design Patients
Modality of ED
assessment Rate of ED Main Finding LoE
Coward et al.35,* RCT 708 men with unexplained
infertility




Gabr et al.14 Case-control 1) 200 men of infertile
couples 2) 200 controls
IIEF-5 ED was higher in the infertile
group (52.5% vs 19%, P
value: 0.001)
Mild (SHIM 17-21): 29%




Severe (SHIM 5-7): 1%
Husband erectile score was
significantly lower in the
infertile group
3
Kizilay et al.15 Case-control 1) 57 azoospermia
2) 41 sperm count <15
million/mL







sperm parameters and IIEF
score
3
Sahin et al.16 Case-control 1) 39 primary infertile men









group (P = .002).
3
Lotti et al.17 Case-control 1) 448 men of infertile
couples
2) 74 age-matched fertile
men
IIEF Group 1: 18.3% reported ED
(IIEF-EF score <26).





ED prevalence increases as a
function of semen quality
impairment severity (P <
.0001)
3
Ozkan et al.18 Case-control 1) 56 infertile men
undergoing in vitro
fertilization therapy
2) 48 fertile men
IIEF Group 1) 84.9% mild-to-
moderate erectile
dysfunction
Group 2) 100% mild-to-
moderate erectile
dysfunction
Being infertile did not cause
significant impairment in
EF compared to the control
group
3
Gao et al.19 Case-control 1) 1,468 infertile men
2) 942 fertile men
IIEF-5 Group 1) ED: 18.05%
Group 2) ED: 8.28%,
The incidence of ED was
higher than those in the
control group
3
Marci et al.20 Case-control Group A: 30 diagnosed
infertile couples
IIEF 26.6% in Group A, 6.66% in




















assessment Rate of ED Main Finding LoE
Group B: 30 infertile
couples
Group C: 52 co-habitant
couples in fertile age
Group A male partners
obtained lower scores in all
the subscales










28% had abnormal IIEF-5
scores
Hypogonadal symptoms and
ED are common among
infertile men
3
Cao et al.22 Cross-sectional
single arm
480 intertile men IIEF-5 55% Anxiety and depression were
both associated with ED in
infertile men
4
Akbal et al.27 Cross-sectional
single arm
66 infertile men submitted
to TESE
IIEF-5 19.6% Unsuccessful TESE
procedures might have a
negative effect on EF
because of hormonal and
psychological reasons
4
Saleh RA et al.23 Cross-sectional
single arm
412 infertile men IIEF-5 11% experienced problems
with erection or orgasm
and had severe anxiety
Some men may experience
sexual dysfunction of a
psychogenic nature in
response to the diagnosis
of infertility
4
Khademi et al.24 cross-sectional
single arm
100 men of infertile couples IIEF ED: 61.6%
Severe ED: 2%
Moderate ED: 5.1%
Mild to moderate ED:
22.2%
Mild ED: 32.3%
The prevalence of any degree





Jain et al.25 Cross-sectional
single arm
175 infertile couples Non-validated
questionnaire
15% Amongst the males,
premature ejaculations was
the most common problem
4
Elia et al.26 Cross-sectional
single arm
171 male partners of sub
fertile couple
IIEF 23.7% There was no significant
variation in the prevalence
of sexual dysfunction






193 infertile couples IIEF 30.1% Greater health literacy was
associated with higher


























assessment Rate of ED Main Finding LoE
Yang et al.29 cross-sectional
single arm
4,299 men of infertile
couples
IIEF-5 Over all 57.8%
Mild: 34.9%







risk factors associated with
ED
4
Song et al.30 Cross-sectional
single arm
260 male of infertile couples IIEF-5 41.5% mild ED
10.4% greater than mild ED
ED was found to be common
in the male partners of
infertile couples
4
Seung-Hun et al.31 cross-sectional
single arm
236 men of infertile couples IIEF-5 Mild ED 42%
Mild to moderate 7.6%
Moderate to severe 1.3%
ED was found to be common













The significant prevalence of
symptoms of ED (31%)




Lotti et al.5 Cross-sectional
single arm
244 men with couple
infertility
IIEF ED was found in 43 (17.8%)
and PE in 38 (15.6%)
subjects
ED is associated with
depressive symptoms,
while PEDT score is
associated with prostatitis
symptoms and signs,
phobic anxiety, and free T
4
Shindel et. al.33 Cross-sectional
single arm
121 infertile couples IIEF 18% had mild ED and 4%
had moderate ED
Depression, ED and sexual
relationship problems are
prevalent among male
partners of infertile couples
4
Hammoud et al.34 Cross-sectional
single arm
526 infertile couples Not reported 9% reported ED The incidence of erectile





















Male Sexual Dysfunctions from ESSM 7also the mirror of an overall poorer health status. Indeed, both
ED and MI are significantly associated with a higher comorbidity
burden.36−38 In line with this theory, Lotti et al observed that
men with worse semen parameters and EF were also less healthy
as assessed with the Chronic Disease Score.17
The psychological distress associated with the inability to con-
ceive and the consequent perceived loss of masculinity are puta-
tive factors for ED among infertile men.39 Depressive symptoms
have been frequently associated with worse EF parameters in
infertile men5,22,23,40: in a cohort of infertile men, Lotti et al.5
showed that depression was the only factor significantly associ-
ated with ED, after adjusting for confounding factors
(OR = 1.19 [1.02 - 1.39]). Moreover, the same group in another
study reported that EF was significantly associated with overall
psychological burden and particularly with somatized anxiety17
Ozkan et al.18 published the only study concluding that being
infertile did not cause significant impairment of EF. They com-
pared 56 infertile men from couples undergoing in vitro fertiliza-
tion and 48 fertile men. Mild-to-moderate ED was detected in
85.9% of men from the infertile group and in 100% of the con-
trol group according to IIEF-5. The high rate of ED observed in
both groups could be the consequence of a possible bias in
patient selection.
2. Treatment
PDE5is are considered the first line therapy for ED according
to international clinical guidelines.41 Overall, 11 RCTs and one
open-label prospective study investigated the safety and efficacy
of PDE5is for the treatment of ED in male partner of infertile
couples (Table 2).42−53 The clinical interest was driven by pre-
clinical evidence showing a possible interaction of certain iso-
forms of PDE enzymes in different steps of semen production
and ejaculation.54 Aversa et al.42 investigated, for the first time in
a double-blind randomized fashion, the effect of one single dose
of 100 mg sildenafil on semen parameters in 20 healthy men vs.
placebo. They showed no changes in seminal parameters after
treatment. Similar results were reported by other authors.43
Interestingly, Pomara et al.48 conducted a small RCT to investi-
gate the effect of a single dose of sildenafil 100 mg vs. tadalafil
20 mg in 18 young infertile men. They reported an increase in
sperm progressive motility after sildenafil (median value 37% vs.
28.5%) as compared to baseline, thus confirming previous find-
ings showing increased sperm kinematical parameters after single
dose of 50 mg sildenafil.47 Similarly, the effect of tadalafil on
sperm parameters was investigated in several trials.44−46,50,53 In a
large RCT, Hellstrom et al.46 tested the effect of daily adminis-
tration of tadalafil 10 or 20 mg vs. placebo in 421 healthy men.
Semen parameters were analyzed after 6 months of treatment
and compared to baseline. In the latter study, the authors did
not find any impact of tadalafil on spermatogenesis and serum
reproductive hormones. The authors confirmed the same results
in a different cohort of patients older than 45 years.50 In an
another placebo-controlled RCT including 20 infertile men withSex Med 2021;9:100377diabetes mellitus and ED, total sperm count, progressive motility
and ejaculate volume were even improved by tadalafil 5 mg daily
for 3 months when compared to placebo.53 Conversely, in the
aforementioned study comparing 100 mg sildenafil vs. 20 mg
tadalafil, Pomara et al.48 reported decreased sperm progressive
motility after tadalafil as compared to baseline (median value
21.5% vs. 28.5%). A positive effect of PDE5is on semen param-
eters was also reported in RCTs investigating the effect of varde-
nafil vs. placebo.49,51 In a cohort of 205 infertile men a single
daily dose of vardenafil 10 mg taken for 15 days led to a signifi-
cant improvement in sperm forward motility, semen volume and
concentration as compared with baseline.49 In a recent meta-
analysis pooling data from 11 RCTs, including 1,317 patients,
the authors reported that acute administration of PDE5is had no
effect on semen volume (Mean difference = 0.26; 95% CI: 0.00-
0.48) and sperm concentration [Mean difference = 2.04; 95%
CI: -2.95 to 7.04], while the rate of motile sperm (Mean Differ-
ence = 7.05; 95% CI: 2.59-11.51), total progressive motility
(Mean Difference = 6.23; 95% CI: 2.43-10.04), and rapid pro-
gressive motility (Mean Difference = 3.11; 95% CI: 0.23-5.99)
were increased after PDE5is administration.55 Interestingly,
these results were significant only in infertile men, suggesting
that at least part of the effect could be caused by normal variation
and regression toward the mean.
Overall, these findings confirm the safety of PDE5is use
among patients seeking fatherhood, with few data suggesting a
possible positive effect on semen parameters. Beside that, the
expected positive effect of PDE5is on EF was also confirmed in
this specific population.
Surprisingly, only one study investigated the impact of treat-
ments other than PDE5is on EF.56 Kobori et al56 evaluated the
effectiveness of antioxidant co-supplementation therapy in 47
adult men with OAT and mild ED. The patients were treated
with a combination of L-arginine 690 mg and French maritime
pine bark extract (Pycnogenol) 60mg. The authors concluded
that after 4 months, the treatment was associated with statisti-
cally significant improvement in total IIEF score (57.69 § 11.04
to 59.43 § 12.57). The sperm concentration was also enhanced
significantly after both 2 and 4 months of treatment (11.79 §
9.86 to 21.22 § 28.17 and 20.15 § 23.99 mil/ml). However,
the study did not show improvement in the IIEF-EF domain
and without a control group, the improvements in both sexual
function score and semen parameters may represent a placebo
effect and natural variation.VALUES
Several studies have demonstrated a relatively high prevalence
of ED among male patients of infertile couples. Due to the lack
of prospective trials, it is not possible to establish a cause-and-
effect relationship. However, the observed association between
depressive symptoms and anxiety and ED detected in men from
infertile couples indicates that underlying mechanisms may be,
Table 2. Studies assessing ED treatment among male partners of infertile couple
Study Design Patients Investigated treatment Main Finding LoE
Aversa et al.42 RCT 20 healthy men Sildenafil 100 mg single dose
vs
Placebo
Sildenafil caused no changes in seminal
parameters when compared to placebo
1
Purvis et al.43 RCT 17 healthy men Sildenafil 100 mg vs. placebo
single dose for two periods
with 5-7 days between doses
These results indicate that a single 100-mg oral
dose of sildenafil does not have an adverse
effect on sperm function or ejaculate quality.
1
Yang et al.44 RCT 20 asthenozoospermic
vs. 20
normozoospermic
Tadalafil 20 mg vs. sildenafil
100 mg 1 dose
After the administration of tadalafil (2 h) and
sildenafil (1 h), there was no significant
difference in semen parameters and in
premature acrosome reaction incidence rate.
1
Corvasce et al.45 Prospective
single-arm
27 men unaware of
fertility status
Tadalafil 5 mg daily for three
months.
Tadalafil improved sperm motility (52.94 % vs.
57.59%); normal morphology (48.91% vs.
54.74%) and semen volume (1.97 vs. 2.38)
compared to baseline.
3
Hellstrom et al.46 RCT 421 healthy men Tadalafil 10 mg daily vs. tadalafil
20 mg daily vs. placebo for 6
months
Chronic daily administration of tadalafil at doses
of 10 and 20 mg for 6 months had no adverse
effects on spermatogenesis
1
du Plessis et al.47 RCT 20 healthy men 50 mg sildenafil 1 dose vs.
placebo
Sildenafil citrate treatment had no effect on both
macroscopic and microscopic seminal
parameters as well as the acrosome reaction.
However, sperm-zona pellucida binding results
were increased to 148.75%
1
Pomara et al.48 RCT 18 infertile men Sildenafil 50 mg vs. tadalafil
20 mg 1 dose.
Significant increase in sperm progressive
motility (median value, 37.0% vs. 28.5%) was
observed after sildenafil administration as
compared with baseline; in contrast, a
significant decreased in semen parameters
was observed after tadalafil (median value,
21.5% vs. 28.5%).
1
Jarvi et al.49 RCT 200 healthy men Vardenafil 20 mg daily vs.
sildenafil 100 mg daily vs.
placebo for 6 months
Vardenafil had no adverse effects on sperm
concentration, compared with sildenafil and
placebo
1
Hellstrom et al.50 RCT 253 healthy men Tadalafil 20 mg daily vs. placebo
for 9 months
This study demonstrated no deleterious effects
of 9 months of daily tadalafil 20mg on
spermatogenesis or hormones related to
testicular function
1
Dimitriadis et al.51 RCT 75 men with
oligoasthenospermia
Vardenafil 10 mg daily (group A)
vs. sildenafil 50 mg daily
(group B) vs. l-carnitine
Increase in sperm concentration (Group A:
10.6 vs. 22.6; Group B: 9.5 vs. 24.3) percent of
motile sperm (Group A: 19.3 vs. 39.2; Group B:


















Study Design Patients Investigated treatment Main Finding LoE
(group C) vs. no treatment
(group D) for 12 weeks
morphologically normal sperm (Group A:
24.3 vs. 40.6; Group B: 23.6 vs. 41.3)
Rago et al.52 RCT 205 infertile men Vardenafil 10 mg 1 dose (group
B) vs. vardenafil 10 mg every
other day for 15 days (group C)
vs. placebo (group A)
Significant increase in percentage forward
motility after vardenafil administration
compared to baseline (Group B: 14.1% vs.
21.8%; Group C: 13.8% vs. 22.7%) In group C,
there was an increase in the mean semen
volume (3.0 mL vs. 3.4 mL) and an
improvement in the mean total sperm
concentration (37.0% vs. 76.1%) as compared
with baseline.
1
La Vignera et al.53 RCT 20 infertile patients with
symptomatic diabetic
neuropathy and ED
Daily administration of 5 mg
tadalafil for 3 months vs.
placebo
Patients showed a significant increase in seminal
vesicles ejection fraction and a significant
improvement in total sperm count, progressive
motility, seminal levels of fructose, leucocytes
and ejaculate volume.
1
Tan et al.55 Meta-analysis 1317 patients PDE5is Acute administration of PDE5is had no effect
on semen volume (MD =0.26; 95% CI: 0.00-
0.48)
The percentage of motile spermatozoa
(MD = 7.05; 95%CI: 2.59-11.51), total
progressive motility (MD = 6.23; 95%CI: 2.43-
10.04), rapid progressive motility (MD = 3.11;
95%CI: 0.23-5.99) and of morphologically
normal spermatozoa (MD = 12.15; 95%CI: 5.16-
19.15) were increased after oral PDE5 inhibitors
treatment in infertile men.
1
Kobori et al.56 Prospective
single-arm
47 men with OAT
syndrome
Combination of L-arginine (690
mg) and French maritime pine
bark extract (60mg)
The sperm concentration was enhanced
significantly after treatment 2 and 4 months
(11.79 § 9.86 to 21.22 § 28.17 and 20.15 §
23.99 £ 106/ml). Significant improvements in
the IIEF were observed in the total score of IIEF
(57.69 § 11.04 to 59.43 § 12.57) after 4
months of treatment
3




















10 Capogrosso et alat least partially, explained by the psychological distress caused
related to the fertility problem. In addition, case-control studies
have indicated that in some cases a correlation between MI and
ED could have a biological background as EF seem to worsen
along with semen parameters.
Several RCTs provided LoE 1 regarding the safety of PDE5is
for the treatment of ED in infertile men and some studies even
indicate that the medication may improve semen parameters.REMARKS
The majority of studies provided low LoE on the association
between ED and infertility. Moreover, current data do not allow
determining the actual impact of ED on male reproductive out-
comes. In spite of this, it seems clear that men from infertile cou-
ples should be screened for sexual dysfunctions and offered
treatment if this is present.
Data showing a possible improvement in seminal parameters
after PDE5is treatment are controversial, thus hampering to
draw conclusions on the positive effects of PDE5is on male
reproductive potential.
Testosterone is crucial for erectile function acting either at
central and peripheral level57,58 Testosterone replacement ther-
apy can improve several aspects of male sexual function in hypo-
gonadal men.57,58 However, it should be recognize that TRT is
contraindicated in men seeking medical care for couple infertility
since it can further worse seminal parameters. The use of hCG or
selective estrogen receptor modulators (SERMs) can represent a
good alternative in the presence of secondary hypogonadism.59
However, no specific study has evaluated the sexual outcomes of
the later drugs in the infertile population.8 Hence, further studies
are advisable in order to better investigate this issue.
EJACULATORY DYSFUNCTIONS
Statements
1 Prevalence and association
 Male partners of infertile couples are at higher risk of reporting
PE (Level 3; Grade C)
 Further studies are needed to determine the prevalence of RE
and anejaculation among male partners of infertile couples
2 Treatment
 Penile vibratory stimulation (PVS) and electroejaculation (EEJ)
are effective treatments for anejaculation in infertile men (Level
2; Grade B)
 PVS seems more effective using a frequency of 100 Hz an ampli-
tude of 2.5 mm compared to an amplitude of 1 mm (Level 2;
Grade B).
 Medical treatment of RE in infertile men with pseudoephedrine,
amoxapine or imipramine can provide antegrade ejaculates
although larger trials are needed (Level 3; Grade C)
 Further studies are needed to determine optimal treatment of
PE among infertile men,Evidence
1. Prevalence and association
Epidemiological studies of EjDs among infertile men are lim-
ited. Currently, three case-control studies5,19,60 and six single-
arm studies17,22,40,61−63 have investigated PE among infertile
men; one case-control64 and one single-arm study65 have looked
at RE, while only one study have investigated the prevalence of
anejaculation among infertile men10 (Table 3).
Of the studies investigating PE, four used the Premature Ejac-
ulation Diagnostic Tool (PEDT) and defined PE as a PEDT
score > 8. The largest of these is a Chinese case-control study
including 1,468 men of infertile couples aged 23 to 45 years and
942 voluntary fertile controls with at least one child.19 The prev-
alence of PE in infertile vs. fertile men was 19.01% vs. 10.93%
(P < .001). The study also evaluated Intravaginal Ejaculation
Latency Time (IELT) and found that a large amount of infertile
men when compared to fertile subjects had an IELT < 1 minute
(11.24% vs. 7.75%, P < .001). The other case-control study
using PEDT compared 448 men from infertile couples with a
mean age of 36.8 years and 74 age-matched healthy fertile con-
trols and found that 12.9% of males from infertile couples had
PE vs. 4.1% of fertile men (P = .036).17 Interestingly, the study
found that azoospermic men had the highest prevalence of PE.
In a retrospective cohort study from the same group, the preva-
lence of PE, based on PEDT, among 244 infertile men was
15.6% with 38.5% reporting lifelong PE and 61.5% reporting
acquired PE.5 In the same study patients with PE were more
likely to report prostatitis symptoms. In this context prostatitis
symptoms have been frequently associated with PE in several
studies66; considering that male accessory gland infection and
inflammation could be a reason for semen impairment, patients
with this condition could be at higher risk of reporting both PE
and fertility issues.
Smaller studies report varying prevalence of PE depending on
the applied definition. Using a self-designed non-validated ques-
tionnaire, a cross-sectional study including 300 infertile men
aged 30.4 years found a PE prevalence of 43% with 74.4%
reporting lifelong PE and 25.6% reporting acquired PE.61
Another cross-sectional study defining PE based on interviews of
sexual performance found a PE prevalence of 14.9% among 268
men form infertile couples.62 Furthermore, a prospective cohort
study found a rate of 50% among 73 men from infertile couples
based on a five-item patient and partner-specific questionnaire
related to PE.40 Finally, two studies investigated the prevalence
of PE among men with Klinefelter Syndrome (KS). The first is a
case-control study including 53 KS patients and 75 age-matched
infertile men without KS.60 Based on the Arabic index for PE
(AIPE ≤ 30) 22.6% of the KS patients had PE compared to
45.3% of the age-matched group (P < .05). The second is also a
case-control study involving 21 men with KS and 1,365 men
attending an outpatient clinic for sexual dysfunction. The defini-
tion of PE was ejaculation occurring always or nearly always priorSex Med 2021;9:100377
Table 3. Studies assessing EjDs among male partners of infertile couples
Study Study Design Patients Modality of assessment Rate of EjD Main Finding LoE
Premature ejaculation




86/440 (19.5%) had PE Anxiety but not depression is
associated with PE
3





12.9% of males from infertile
couples had PE vs. 4.1% of




El Bardisi et al.60 Case-control 53 men with Klinefelter







12/53 (22.6%) of KS men had
PE vs. 34/75 (45.3%) controls
(P < .05)
The prevalence of PE in KS
men is significantly lower
compared to age-matched
infertile men without KS.
3
Gao et al.19 Case-control 1468 infertile men and 942
fertile controls
PEDT (PEDT score >8)
IELT
PE based on PEDT: 19.01%
vs.10.93%, P < .001
IELT:
<1min: 11.24% vs. 7.75%
1 ≤ 2 min: 18.80% vs. 13.69%
Infertile men reported higher
rates of anxiety and
depression.
3
Lotti et al.5 Cross-sectional
single arm
244 infertile men PEDT
(PEDT score >8)
PE in 38/244 (15.6%) of infertile
men
Among these, 38.5% had
lifelong PE and 61.5% acquired
PE
ED and PE are reported by






300 infertile men Self-designed, non-
validated questionnaire
43% of patients had PE
Among these, 74.4% had
lifelong PE and 25.6%
acquired PE
51.2% of patients with PE
reported time to ejaculation
less than 1 min
High frequency of PE among
infertile men.
4
Omu et al.62 Cross-sectional
single arm
268 infertile men Interview on sexual
performance




Corona et al.63 Retrospective
cohort
21 men with KS PE defined as ejaculation
occurring always or
nearly always prior to or
within about 1 min
2/21 (9.5%) had PE Sexual dysfunction in KS is
caused by the underlying
hypogonadal state
4




50% reported PE Self-reported PE is prevalent
among infertile men. PE is
associated with lower
relationship satisfaction in
















































































































































































































































































































































































































































































































12 Capogrosso et alto or within about 1 minute. A total of 2/21 of the KS men
(9.5%) had PE and after adjustment for age with no difference
when compared to controls.
Only two studies investigated RE rate among infertile men. In
a case-control study comparing 245 infertile men with a semen
volume < 2 ml with 162 infertile men with a semen volume >
2 ml, 6% vs. 7% had sperm in the post-ejaculatory urine sample
and was diagnosed with RE.64 In a retrospective cohort study,
involving 920 infertile men, RE was found in four (4%) out of
96 of azoospermic subjects.65
Regarding anejaculation, Punab et al.10 showed that, in a
large prospective clinical-epidemiological study investigating
causes of male infertility, anejaculation accounted for 1.2% of all
causes. Spinal cord injury (SCI) was the main cause of anejacula-
tion accounting for 65% of cases, followed by diabetes mellitus
and multiple sclerosis. Interestingly, in up to 15% of patients
with anejaculation no organic cause was detected, thus suggesting
a possible psychogenic etiology10
2. Treatment
The majority of studies investigating treatment of EjDs in infer-
tile men are dealing with anejaculation or RE (Table 4). Conversely,
we identified only three studies specifically addressing possible
improvement in PE among infertile men affected by varicocele.
In a prospective study, the authors investigated the effect of vari-
cocelectomy on PE in a cohort of infertile men with both varicocele
and PE.67 The working hypothesis being that reducing blood
refluxing would increase fertility and improve PE.68,69 A total of 51
men underwent varicocelectomy which resulted in a significant
increase in IELT (P < .05). No sperm counts were reported. The
effect of varicocele treatment on PE have been investigated in other
two studies70,71; however, both of them were conducted on patients
with semen impairment but no evidence of couple infertility and
for this reason they will not be taken in account in our analysis.
Several medical approaches have been investigated in order to
achieve antegrade ejaculation for natural reproduction in patients
with RE. The tested substances include imipramine (tri-cyclic
antidepressant), amoxapine (tri-cyclic antidepressant), B12 vita-
min, pseudoephedrine (stimulation of a and b receptors in the
urinary tract) as well as injection of collagen within the bladder
neck.72−76 One cross-over RCT treated 26 patients with amoxa-
pine (50 mg daily) and B12 vitamin (500 ug 3 times per day),
separately for a period of 4 weeks with each drug.73 Amoxapine,
which acts as a noradrenaline re-uptake inhibitor, was effective in
80% of patients compared to only 16% success obtained in the
vitamin B12 group. In another study, comparing the effects of
imipramine 25 mg twice per day and pseudoephedrine 120 mg
twice per day on RE in diabetic men, Arafa et al.75 found a more
moderate success rate of 38.5% with imipramine. However, the
use of pseudoephedrine resulted in almost half of the patients
having antegrade ejaculation and this increased to 61.5% when
combining the two drugs. Of note, the side-effects of sympatho-
mimetics include dryness of mucous membranes andSex Med 2021;9:100377
Table 4. Treatment of EjDs in male partners of infertile couples
Study Study Design Patients Investigated treatment Main Finding LoE
PE
Hosseini et al.67 Prospective clinical trial 51 infertile men with PE and





increase in urine Dopamine




Shoshany et al.72 Retrospective cohort 20 men with RE (12
complete, 8 partial)
60mg pseudoephedrine
every 6 h on the day before
semen analysis and
2 £ 60 mg on the day of
semen analysis
7/12 (58%) complete RE
recovered spermatozoa in
an antegrade ejaculate
5/8 partial RE had ≥ 50%
increase in antegrade total
sperm count
3
Hu et al.73 RCT 26 men with complete RE (13
in each group)
Amoxapine 50mg daily for 4
weeks! 1 week
washout! Vit B12 500ug
3 times per day for 4
weeks
Crossover to:
Vit B12 500 ug 3 times per
day for 4 weeks
! 1 week
washout! Amoxapine




Vit B12: 4/25 (16%)
2
Kurbatov et al.74 RCT 24 men with complete RE
due to DM1 refractory to







(mean difference: 0.71ml, P
< .05)
2
Arafa et al.75 Prospective clinical trial 33 RE patients due to
diabetes (23 complete, 10
partial)
Three sequential courses:
Imipramine 25 mg twice/
day, pseudoephidrine
120 mg twice/day, or












parameters in all groups
3




25 to 50 mg for 7 days

























Study Study Design Patients Investigated treatment Main Finding LoE
ejaculation or expected
ovulation of female partner
Anejaculation
Meng et al.77 Retrospective cohort 20 men with psychogenic
anejaculation refractory to
PVS
EEJ Successful retrieval in all
men
2*
Soeterik et al.78 Retrospective cohort 47 SCI men EEJ Spermatozoa found in 199/
230 EEJ attempts (86.5%)
2*
Castle et al.95 Prospective cohort 30 SCI men PVS Successful retrieval in 23/30
(76.7%) of the men
2*
Meng et al.98 Case-control 91 idiopathic anejaculation
vs. 60 healthy fertile
controls




In the control group:
masturbation
Successful retrieval in all
men (10 from NE, 40 from
PVS, 41 from EEJ and from
masturbation in all 60
controls)
4
Gat et al.88 Retrospective cohort 15 men with psychogenic
anejaculation and 22 SCI
men
EEJ Successful retrieval in all
men
2*
McGuire et al.89 Retrospective cohort 31 SCI men EEJ Successful retrieval in all
men
2*
Das et al.91 Retrospective cohort 16 SCI men Repeated EEJ to improve
semen parameters
No improvement in volume,
concentration, motility or





Hovav et al.92 Retrospective cohort 59 neurologically intact men
with anejaculation




for antegrade volume (0.33
+/- 0.16 ml)
2*
Hovav et al.93 Retrospective cohort 25 men with psychogenic
anejaculation
EEJ Successful retrieval in all
men
2*
Ohl et al.94 Retrospective cohort 121 men with anejaculation
(118 neurogenic, 3
psychogenic)
EEJ 52 couples became pregnant
(43%)
2*
Heruti et al.79 Retrospective cohort 84 SCI men EEJ Successful retrieval in all
men
2*
Schatte et al.80 Prospective cohort 17 men with anejaculation (10
SCI, 5 RPLND, 2 idiopathic)



















Study Study Design Patients Investigated treatment Main Finding LoE
Chung et al.81 Retrospective cohort 13 anejaculatory men (7
RPLND, 1 SCI, 5
psychogenic)
EEJ Successful retrieval in all
men
2*






in C3-C7 followed by T1-
T5, T6-T10 and T11-L3.
2*
Chung et al.86 Retrospective cohort 26 men with anejaculation
(23 SCI, 3 RPLND)
EEJ 77/84 (91.6%) of EEJ
procedures successful
defined by at least 10mio
sperm found
2*
Hulting82 Retrospective cohort 10 men with anejaculation/
RE due to treatment of
testis cancer
EEJ Successful retrieval in 9/10
(90%) of the men
2*
Sønken et al.97 Prospective clinical trial 66 SCI men PVS with 1mm or 2.5mm
amplitude
Retrieval rates:
In the first group (n=25):
1mm = 32%
2.5mm = 96%
In the second group (n=41):
2.5mm = 83%
2*
Wang et al.83 Retrospective cohort 25 SCI men EEJ Successful retrieval in 22/25
(88%) of the men:
Bi-directional emission was
found in 12 patients,
antegrade in nine,
retrograde in one and
failure in three.
2*
Denil et al.84 Retrospective cohort 198 men with anejaculation EEJ At least 10 mio progressively
motile sperm was obtained
in:
- 75% of SCI men
- 87% of men following
RPLND
2*
Lucas et al.85 Retrospective cohort 14 anejaculatory men EEJ Successful retrieval in
21/26 (80.8%) of the men
2*




















16 Capogrosso et alhypertension. Exploring a different approach to the problem,
Kurbatov et al. injected collagen into the bladder neck to increase
the constriction of the internal sphincter.74 A total of 24 diabetic
men were randomized to either a collagen or a saline injection,
showing a small increase in antegrade ejaculate with a mean dif-
ference of 0.71 ml in favor of patients receiving collagen (P <
.05).
In general, EEJ77−94 and PVS95−97 are the two treatment
options investigated for sperm retrieval in men with anejaculation.
Retrieval rates with EEJ have been reported to range between 75%
and 100%, mainly depending on whether the outcome measure
was simply sperm retrieval or a specific quantity of motile
sperm.78,79,81,84 In this context, results from a retrospective study,
including 84 men with SCI, showed that when stimulated with a
rectal probe EEJ, 98.6% of the patients achieved ejaculation and
motile sperms were found in 88.1% of the samples.79 In a similar
cohort of 198 men including both SCI and retroperitoneal lymph
node dissection (RPLND) as causes for anejaculation, Denil et al.84
obtained ejaculates with EEJ with sperm counts of > 10 mil/ml in
75% and 87% of the SCI and RPLND group, respectively.
Three studies have investigated success rates with vibratory
stimulation of the dorsal penile nerve and achieved successful
retrieval in 32% to 96% of the patients.95−97 Success was pri-
marily dependent on amplitude of the stimulation. In a cohort
of 66 men with SCI and anejaculation, Sønksen et al.97 found
better success rates with a 100 Hz frequency and an increasing
amplitude of the stimulation plate spanning from 32% with an
amplitude of 1 mm, to 96% with an amplitude of 2.5 mm. In a
similar setting with 211 SCI men, Brackett et al.96 managed
good results using an amplitude of 2.5 mm, resulting in sperm
retrieval in 54.4% of the cases. Interestingly, there seem to be a
better sperm quality with PVS as compared to EEJ.98
Values
Based on the limited epidemiological evidence using validated
tools to investigate PE among infertile men, we found that male
partners of infertile couples are at higher risk of reporting PE,
which is likely to be associated with increased psychological dis-
tress of men from infertile couples. Only two observational stud-
ies reported RE among infertile men, while no studies
investigated the prevalence of anejaculation among infertile men.
Case-control and single-arm trials have produced convincing
results on PVS and EEJ for the treatment of anejaculation in infer-
tile men. Of note, these procedures are not devoid of side effects
including skin abrasion, penis edema, and autonomic dysreflexia
in men with a history of SCI. However, these potential side-effects
can be safely mitigated by observing the penile skin during PVS
and by pre-treating men prone to autonomic dysreflexia with anti-
hypertensive medication such as nifedipine.99 Medical treatment
of RE in infertile men have been investigated in RCTs with pseu-
doephedrine, amoxapine or imipramine showing positive results.
In case of treatment failure, sperm retrieval from alkalinized urine
represents a valuable option.2 However, the number of patientsstudied is limited and the quality of the available studies is overall
poor. Further studies are needed to determine optimal treatment
of PE among infertile men.REMARKS
Although PE seems more prevalent among men from infertile
couples, available studies are heterogeneous in the definition of
PE and in the population characteristics. Further, few studies
were specifically aimed to investigate the prevalence of PE among
infertile men. Only two observational studies investigating RE
among infertile men were available. Both suffer from selection
bias, as one64 selected patients based on ejaculate volume and the
other65 only reported RE among azoospermic men. Only one
study investigated the prevalence of anejaculation in a cohort of
unselected infertile men10
There is a shortage of RCTs investigating the treatment of
anejaculation in infertile men and thus LoE 1 is currently lack-




1 Prevalence and association:
 Male partners of infertile couples may suffer from LSD in about
one third of cases. Patients with severe male factor infertility and
longer duration of infertility are at higher risk of LSD (Level 3;
Grade C)
2 Treatment:
 Due to the lack of available data, no recommendation can be
given on LSD treatment in male partners of infertile couples.EVIDENCE
Epidemiological studies on LSD among infertile men are lim-
ited. Currently, four case-control studies17,20,100,101 and six
observational studies24,26,102−105 have investigated the preva-
lence of LSD among men from infertile couples (Table 5).
Lotti et al.17 compared 448 men of infertile couples with a
mean age of 36.8 years and 74 age-matched healthy fertile con-
trols. Infertile men were divided into a group of 96 azoospermic
men, a group of 245 men with at least one semen alteration and
a group of 107 men with normal semen parameters. Results
showed that azoospermic men had significantly lower sexual
desire compared to fertile controls according to the IIEF-Sexual
Desire domain (7.4 vs 7.9; P < .05). There was no difference
between the groups of infertile men with semen abnormalities or
those with normal semen parameters as compared with the fertile
controls. In another case-control study100 including 61 men
with non obstructive azoospermia, 69 with severe oligospermia
and 60 fertile men, the authors found the prevalence of LSD (as
assessed with a single question) to be 8%, 4%, and 0% respec-
tively.Sex Med 2021;9:100377
Table 5. Studies assessing LSD among male partners of infertile couples
Study Design Patients Modality of SD assessment Rate of LSD Main Findings LoE
van Zyl JA et al.102 cross-sectional
single arm study
514 male patients of infertile
couples





Giannouli C et al.100 case-control study 61 men with idiopathic non-
obstructive azoospermia
vs. with 69 men with
known causes of infertility
vs. 60 fertile men
not provided 8% in idiopathic NOA, 4% in
infertile of known cause,






200 men of infertile couples Sexual desire graded in a 5-
points Likert scale
N/R - Longer duration of rela-
tionship, of history of
infertility, of treatment for
infertility and ageing corre-
lated with worse sexual
desire
- greater coitus frequency,
mutual understanding
within the couple and
present sexual satisfaction
correlated with better sex-
ual desire
4
Khademi A et al.24 cross-sectional
single armstudy
100 male patients of infertile
couples
IIEF-SD domain N/R  No relationship between
degree of sexual desire and
male or female age, dura-
tion of infertility, male edu-
cation, type of infertility,
family income.
4
Elia J et al.26 cross-sectional
single arm study
156 men of infertile couples IIEF-SD domain N/R - Significantly lower score in
men having sex for repro-
duction than the same
men having sex for plea-
sure and the same men
having sex before starting
to conceive a baby
4
Marci R et al.20 case-control study 30 men from infertile
couples (recent diagnosis),
30 men from infertile
couples (already
undergoing IUI),
52 control with no history
or suspicious infertility
IIEF-SD domain N/R  Significantly lower IIEF-SD
score in infertile men as
compared with controls
 No difference in IIEF-15-SD
scoree between men with
























Study Design Patients Modality of SD assessment Rate of LSD Main Findings LoE












1750 men evaluated for
infertility
Androgen Deficiency in the
Aging Male (ADAM)
26.6% - Prevalence of 45.2% of
androgen deficiency symp-
toms and 19.9% of ED in
MI men with low libido
- TT and BioT associated
with low libido
- Age, medications, DM and
hypertension associated
with low libido
- PRL, E2 and gonadotro-
pins not associated with
low libido
4
Lotti F et al.17 case-control study 448 male patients evaluated
for couple infertility + 74
fertile controls
IIEF-SD domain N/R  Significantly lower IIEF-SD
score in azoospermic men
as compared with fertile
men.
 No differences in IIEF-SD
score between infertile
men with at least 1 altered












28.9% No association with attachment
anxiety or avoidance and
HSDD in infertile men
4




N/R OR for low desire in infertile
men: - 2.1 (1.2-3.8) p=0.02
after infertility
treatment
- 1.1 (0.5-2.2) p=0.84 at the
beginning of workup for
infertility
3















Male Sexual Dysfunctions from ESSM 19Marci et al.,20 studied LSD in a group of 60 men of infertile
couples compared to 52 male partners of women attending for
routine gynecologic testing. Based on the IIEF-SD domain, sex-
ual desire was significantly lower in men from the infertile cou-
ples compared to controls. A recent case-control study by Kruljac
et al.101 compared 165 men with sperm counts < 15 mil/mL
and 199 fertile age-matched controls. The Sexual Complaints
Screener for Men (SCS-M) was utilised. When compared to con-
trols, LSD was significantly more prevalent among infertile hypo-
gonadal men in comparison to fertile controls but not in infertile
men who were eugonadal [OR (95% CI): 2.3 (1.0-5.5);
P = .05 vs. 1.5 (0.89-2.7); P = .12]. In addition, LSD was signifi-
cantly more reported by men who have completed infertility
treatment rather than men at initial infertility screening [OR
(95% CI): 2.1 (1.2-3.8); P = .02 vs 1.1 (0.5-2.2)].
Other observational studies described the prevalence of LSD
in male partners of infertile couples. Using a specific question-
naire, Satkunasivam et al.32 reported LSD in 26.6% of 1,750
men who presented for infertility evaluation at one center. Inter-
estingly, although the authors reported a high prevalence of
patients with low level of total or bioavailable T, suggesting
androgen deficiency (45.2%), they did not find an association
between total, bioavailable T levels and low libido. Therefore,
the authors speculate that the high prevalence of low libido in
their cohort was secondary to psychological factors associated
with the stress and anxiety of infertility and infertility treatments.
Another specific questionnaire-based study by Purcell-Levesque
et al.105 showed a LSD prevalence of 28.9% in 45 male partners
from infertile couples. Although the study found no association
between attachment related anxiety and low libido, they did find
avoidance secondary to female partner’s difficulty in reaching
orgasms.
Another study by Elia et al.26 evaluated 156 men of infertile
couples using a modified version of the IIEF. Unlike other stud-
ies, no correlation was found between LSD and semen parame-
ters; however, none of the patients in the study group were
azoospermic.VALUES
Based on the limited epidemiological evidence of LSD among
infertile men, we found that male partners of infertile couples are
at higher risk of reporting low desire. According to studies using
a validated questionnaire to assess sexual desire, we found that
LSD is reported in up to a third of cases. Low desire in infertile
men may be more prevalent in azoospermic and severe oligosper-
mic men than other groups of sub fertile men and could be
related to hormonal, psychological and interpersonal factors.REMARKS
Only a few studies looked into the prevalence of LSD in infer-
tile men. Moreover, some studies also looked into SDs in generalSex Med 2021;9:100377rather than specifically addressing desire and sometimes the
emphasis was on ED. No data are available regarding the man-
agement of LSD in infertile patients. Likewise no studies evalu-
ated the effect of hormonal treatment on sexual desire in infertile
populations (see above).CONCLUSIONS
Sexual dysfunctions are frequently reported by male patients
of infertile couples, potentially affecting both sexual QoL and
reproductive outcomes.
The available evidence suggests that ED may be found in a
relatively large proportion of patients affected by couple infertil-
ity although prevalence rates differ widely. The evidence suggests
that the psychological consequence of MI could significantly
affect EF. Indeed, published data confirmed a strong correlation
between depressive symptoms and erectile difficulties5,22,23,40
which may be ascribed both to a feeling of loss of masculinity and
to the psychological pressure related to the difficulty to conceive.
Moreover, data suggest a positive correlation between the severity
of seminal parameters abnormalities and the risk of ED, which
could be the consequence of both a higher psychological distress
associated to a more severe impairment of reproductive function
and to an overall worse health status, which has been largely asso-
ciated with both MI and ED. Whether ED per se could be consid-
ered a direct cause of poor reproductive function is currently
unknown. However, treating ED appears crucial to ensure an
effective sexual relationship aimed to increase both the chance of
conceiving and the QoL of the couple. Level 1 data have demon-
strated the safety of PDE5is in male patients looking for father-
hood and represent therefore the first line of treatment according
to clinical guidelines. Furthermore, infertile patients suffering from
ED should be carefully screened for possible metabolic and hor-
monal abnormalities potentially associated with both conditions.
Last, psychological counselling should be considered when the psy-
chogenic factor appears relevant to the EF impairment.
Ejaculatory dysfunctions could be a rare cause of MI. There is
consistent evidence from non-randomized studies regarding the
efficacy of EEJ and PVS for treating anejaculation in infertile
men with neurological diseases. Oral treatment with sympatho-
mimetic and tricyclic antidepressant agents could be of value for
the treatment of RE, although larger trials are needed to provide
strong data on the efficacy of these drugs. Although ejaculatory
dysfunctions account only for a small number of cases of MI,
they should be carefully investigated and detected since effective
treatments are available.
Furthermore, infertile men should be carefully assessed for
PE, which seems to affect a non-negligible rate of patients and
deserve to be treated according to clinical guidelines. As for ED,
the main reason for PE among infertile men rely on the psycho-
logical burden associated with the forced timing of intercourse
and the difficulty to conceive. Of clinical relevance, PE may also
be associated with prostatitis in some cases,66 which could be
20 Capogrosso et alalso a reason for semen impairment. Studies assessing the effect
of conventional treatment of PE among infertile men or men of
infertile couple are currently lacking.
The psychological distress associated with MI could also lead
to LSD. Infertile men or male partners of infertile couples may
suffer from low desire with a significant impairment of their sex-
ual activity. Moreover, LSD could be a symptom of systemic
conditions, which may also affect fertility.
This systematic review is not devoid of limitations; most of
the included studies were retrospective or single-arm studies thus
lowering the level of evidence of the reported findings. Moreover,
according to our protocol only one database was used for the lit-
erature search, thus some eligible studies may have been missed.
Overall, data from this systematic review highlight the impor-
tance of discussing also potential sexual issues among patients
seeking help for couple infertility.AKNOWLEDGMENTS
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27. Akbal C, Mangir N, Tavukçu HH, et al. Effect of testicular
sperm extraction outcome on sexual function in patients
with male factor infertility. Urology 2010. doi: 10.1016/j.
urology.2009.07.1330.
28. Sahebalzamani M, Mostaedi Z, Farahani H, et al. Relationship
between health literacy and sexual function and sexual satis-
faction in infertile couples referred to the royan institute. Int
J Fertil Steril 2018. doi: 10.22074/ijfs.2018.5185.
29. Yang B, Xu P, Shi Y, et al. Erectile dysfunction and associ-
ated risk factors in Chinese males of infertile couples. J Sex
Med 2018. doi: 10.1016/j.jsxm.2018.02.019.
30. Song SH, Kim DS, Yoon TK, et al. Sexual function and stress
level of male partners of infertile couples during the fertile
period. BJU Int 2016. doi: 10.1111/bju.13201.
31. Seung-Hun S, Dong-Suk KIM, Sung-Han S, et al. Usage and
perceptions of phosphodiesterase type 5 inhibitors among the
male partners of infertile couples. Clin Exp Reprod Med
2016;43:26–30.
32. Satkunasivam R, Ordon M, Hu B, et al. Hormone abnormali-
ties are not related to the erectile dysfunction and decreased
libido found in many men with infertility. Fertil Steril 2014.
doi: 10.1016/j.fertnstert.2014.02.044.
33. Shindel AW, Nelson CJ, Naughton CK, et al. Sexual function
and quality of life in the male partner of infertile couples:
Prevalence and correlates of dysfunction. J Urol 2008. doi:
10.1016/j.juro.2007.10.069.
34. Hammoud AO, Wilde N, Gibson M, et al. Male obesity and
alteration in sperm parameters. Fertil Steril 2008. doi:
10.1016/j.fertnstert.2007.10.011.
35. Coward RM, Stetter C, Kunselman A, et al. Fertility related
quality of life, gonadal function and erectile dysfunction in
male partners of couples with unexplained infertility. J Urol
2019. doi: 10.1097/ju.0000000000000205.
36. Capogrosso P, Ventimiglia E, Boeri L, et al. Male infertility as
a proxy of the overall male health status. Minerva Urol eSex Med 2021;9:100377Nefrol 2018;70:286–299. doi: 10.23736/S0393-
2249.18.03063-1.
37. Salonia A, Castagna G, Sacca A, et al. Is erectile dysfunction
a reliable proxy of general male health status? The case for
the international index of erectile function-erectile function
domain. J Sex Med 2012;9:2708–2715. doi: 10.1111/j.1743-
6109.2012.02869.x.
38. Maseroli E, Corona G, Rastrelli G, et al. Prevalence of endo-
crine and metabolic disorders in subjects with erectile dys-
function: A comparative study. J Sex Med 2015. doi: 10.1111/
jsm.12832.
39. Lenzi A, Lombardo F, Salacone P, et al. Stress, sexual dys-
functions, and male infertility. J Endocrinol Invest
2003;26:72–76.
40. Shindel AW, Nelson CJ, Naughton CK, et al. Premature ejac-
ulation in infertile couples: Prevalence and correlates. J Sex
Med 2008. doi: 10.1111/j.1743-6109.2007.00690.x.
41. Hatzimouratidis K, Giuliano F, Moncada I, et al. EAU guide-
lines on erectile dysfunction, premature ejaculation, penile
curvature and priapism.. Eur Assoc Urol 2017 Available at:
https://uroweb.org/guideline/sexual-and-reproductive-
health/. Accessed May 24, 2021.
42. Aversa A, Mazzilli F, Rossi T, et al. Effects of sildenafil
(Viagra(TM)) administration on seminal parameters and
post-ejaculatory refractory time in normal males. Hum
Reprod 2000. doi: 10.1093/humrep/15.1.131.
43. Purvis K, Muirhead GJ, Harness JA. The effects of sildenafil
citrate on human sperm function in healthy volunteers. Br J
Clin Pharmacol 2002 Suppl. doi: 10.1046/j.0306-
5251.2001.00033.x.
44. Yang Y, Ma Y, Yang H, et al. Effect of acute tadalafil on
sperm motility and acrosome reaction: In vitro and in vivo
studies. Andrologia 2014. doi: 10.1111/and.12097.
45. Corvasce A, Albino G, Leonetti T, et al. Once-A-day Tadalafil
administration improves the spermogram parameters in fer-
tile patients. Arch Ital Di Urol e Androl 2015. doi: 10.4081/
aiua.2015.3.210.
46. Hellstrom WJG, Overstreet JW, Yu A, et al. Tadalafil has no
detrimental effect on human spermatogenesis or reproduc-
tive hormones. J Urol 2003. doi: 10.1097/01.
ju.0000081053.97792.da.
47. Du Plessis SS, De Jongh PS, Franken DR. Effect of acute in
vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments
on semen parameters and sperm function. Fertil Steril
2004. doi: 10.1016/j.fertnstert.2003.09.054.
48. Pomara G, Morelli G, Canale D, et al. Alterations in sperm
motility after acute oral administration of sildenafil or tadala-
fil in young, infertile men. Fertil Steril 2007. doi: 10.1016/j.
fertnstert.2006.12.019.
49. Jarvi K, Dula E, Drehobl M, et al. Daily vardenafil for 6
months has no detrimental effects on semen character-
istics or reproductive hormones in men with normal
baseline levels. J Urol 2008. doi: 10.1016/j.
juro.2007.10.077.
22 Capogrosso et al50. Hellstrom WJG, Gittelman M, Jarow J, et al. An evalua-
tion of semen characteristics in men 45 years of age or
older after daily dosing with tadalafil 20 mg: Results of a
multicenter, randomized, double-blind, placebo-controlled,
9-month Study. Eur Urol 2008. doi: 10.1016/j.eur-
uro.2007.09.046.
51. Dimitriadis F, Tsampalas S, Tsounapi P, et al. Effects of
phosphodiesterase-5 inhibitor vardenafil on testicular andro-
gen-binding protein secretion, the maintenance of foci of
advanced spermatogenesis and the sperm fertilising capacity
in azoospermic men. Andrologia 2012. doi: 10.1111/j.1439-
0272.2010.01153.x.
52. Rago R, Salacone P, Caponecchia L, et al. Effect of vardenafil
on semen parameters in infertile men: A pilot study evaluat-
ing short-term treatment. J Endocrinol Invest 2012. doi:
10.3275/8368.
53. La Vignera S, Condorelli RA, Vicari E, et al. Seminal vesicles
and diabetic neuropathy: Ultrasound evaluation after prolonged
treatment with a selective phosphodiesterase-5 inhibitor.
Andrology 2013. doi: 10.1111/j.2047-2927.2012.00025.x.
54. Dimitriadis F, Giannakis D, Pardalidis N, et al. Effects of
phosphodiesterase 5 inhibitors on sperm parameters and
fertilizing capacity. Asian J Androl 2008. doi: 10.1111/j.1745-
7262.2008.00373.x.
55. Tan P, Liu L, Wei S, et al. The effect of oral phosphodiester-
ase-5 inhibitors on sperm parameters: A meta-analysis and
systematic review. Urology 2017. doi: 10.1016/j.urol-
ogy.2017.02.032.
56. Kobori Y, Suzuki K, Iwahata T, et al. Improvement of seminal
quality and sexual function of men with oligoasthenoterato-
zoospermia syndrome following supplementation with L-
Arginine and Pycnogenol. Arch Ital Di Urol e Androl 2015.
doi: 10.4081/aiua.2015.3.190.
57. Rastrelli G, Guaraldi F, Reismann Y, et al. Testosterone
replacement therapy for sexual symptoms. Sex Med Rev
2019. doi: 10.1016/j.sxmr.2018.11.005.
58. Salonia A, Rastrelli G, Hackett G, et al. Paediatric and adult-
onset male hypogonadism. Nat Rev Dis Prim 2019. doi:
10.1038/s41572-019-0087-y.
59. Awouters M, Vanderschueren D, Antonio L. Aromatase
inhibitors and selective estrogen receptor modulators:
Unconventional therapies for functional hypogonadism?
Andrology 2020. doi: 10.1111/andr.12725.
60. El Bardisi H, Majzoub A, Al Said S, et al. Sexual dysfunction
in Klinefelter’s syndrome patients. Andrologia 2017. doi:
10.1111/and.12670.
61. Hassanzadeh K, Yavari-Kia P, Ahmadi-Asrbadr Y, et al. Fea-
tures of premature ejaculation in infertile men. Pakistan J
Biol Sci 2010. doi: 10.3923/pjbs.2010.911.915.
62. Omu FE, Omu AE. Emotional reaction to diagnosis of infertility
in Kuwait and successful clients’ perception of nurses’ role dur-
ing treatment. BMC Nurs 2010. doi: 10.1186/1472-6955-9-5.
63. Corona G, Petrone L, Paggi F, et al. Sexual dysfunction in
subjects with Klinefelter’s syndrome. Int J Androl 2010. doi:
10.1111/j.1365-2605.2009.00986.x.64. Mieusset R, Walschaerts M, Isus F, et al. Diagnosis of partial
retrograde ejaculation in non-azoospermic infertile men with
low semen volume. PLoS One 2017. doi: 10.1371/journal.
pone.0168742.
65. Lee HD, Lee HS, Park SH, et al. Causes and classification of
male infertility in Korea. Clin Exp Reprod Med 2012. doi:
10.5653/cerm.2012.39.4.172.
66. Sihotang RC, Alvonico T, Taher A, et al. Premature ejacula-
tion in patients with lower urinary tract symptoms: A sys-
tematic review. Int J Impot Res 2020. doi: 10.1038/
s41443-020-0298-5.
67. Hosseini SR, Mohseni MG, Alizadeh F. Impact of varicocelec-
tomy on urine dopamine value in patients with premature
ejaculation and varicocele. Andrologia 2019. doi: 10.1111/
and.13398.
68. Gat Y, Gornish M, Heiblum M, et al. Reversal of benign pros-
tate hyperplasia by selective occlusion of impaired venous
drainage in the male reproductive system: Novel mechanism,
new treatment. Andrologia 2008. doi: 10.1111/j.1439-
0272.2008.00883.x.
69. Lotti F, Corona G, Mancini M, et al. The association between
varicocele, premature ejaculation and prostatitis symptoms:
Possible mechanisms. J Sex Med 2009. doi: 10.1111/j.1743-
6109.2009.01417.x.
70. Asadpour AA, Aslezare M, Adkani LN, et al. The effects of
varicocelectomy on the patients with premature ejacula-
tion. Nephrourol Mon 2014. doi: 10.5812/
numonthly.15991.
71. Ahmed AF, Abdel-Aziz AS, Maarouf AM, et al. Impact of var-
icocelectomy on premature ejaculation in varicocele patients.
Andrologia 2015. doi: 10.1111/and.12256.
72. Shoshany O, Abhyankar N, Elyaguov J, et al. Efficacy of
treatment with pseudoephedrine in men with retrograde
ejaculation. Andrology 2017. doi: 10.1111/andr.12361.
73. Hu J, Nagao K, Tai T, et al. Randomized crossover trial of
amoxapine versus vitamin B12for retrograde ejaculation. Int
Braz J Urol 2017. doi: 10.1590/S1677-5538.
IBJU.2016.0468.
74. Kurbatov D, Russo GI, Galstyan GR, et al. Correction of retro-
grade ejaculation in patients with diabetes mellitus using
endourethral collagen injection: Preliminary results. J Sex
Med 2015. doi: 10.1111/jsm.13024.
75. Arafa M, El Tabie O. Medical treatment of retrograde
ejaculation in diabetic patients: A hope for spontaneous
pregnancy. J Sex Med 2008. doi: 10.1111/j.1743-
6109.2007.00456.x.
76. Ochsenk€uhn R, Kamischke A, Nieschlag E. Imipramine for
successful treatment of retrograde ejaculation caused by ret-
roperitoneal surgery. Int J Androl 1999. doi: 10.1046/
j.1365-2605.1999.00165.x.
77. Meng X, Fan L, Wang T, et al. Electroejaculation com-
bined with assisted reproductive technology in psycho-
genic anejaculation patients refractory to penile vibratory
stimulation. Transl Androl Urol 2018. doi: 10.21037/
tau.2018.01.15.Sex Med 2021;9:100377
Male Sexual Dysfunctions from ESSM 2378. L T, S T, O R. Electroejaculation performed in patients with
spinal cord lesion-a single center 21 years experience. J Urol
2016.
79. Heruti RJ, Katz H, Menashe Y, et al. Treatment of male
infertility due to spinal cord injury using rectal probe electroe-
jaculation: The Israeli experience. Spinal Cord 2001;39:168–
175. doi: 10.1038/sj.sc.3101120.
80. Schatte EC, Orejuela FJ, Lipshultz LI, et al. Treatment of infer-
tility due to anejaculation in the male with electroejaculation
and intracytoplasmic sperm injection. J Urol 2000;163:1717–
1720. doi: 10.1016/S0022-5347(05)67527-1.
81. Chung PH, Verkauf BS, Eichberg RD, et al. Electroejaculation
and assisted reproductive techniques for anejaculatory infer-
tility. Obstet Gynecol 1996;87:22–26. doi: 10.1016/0029-
7844(95)00335-5.
82. Hultling C, Rosenlund B, T€ornblom M, et al. Transrectal elec-
troejaculation in combination with in-vitro fertilization: An
effective treatment of anejaculatory infertility after testicular
cancer. Hum Reprod 1995;10:847–850. doi: 10.1093/
oxfordjournals.humrep.a136048.
83. Wang YH, Chiang HS, Wu CH, et al. Electroejaculation in spinal
cord injured males. J Formos Med Assoc 1992;91:413–418.
84. Denil J, Ohl DA, McGuire EJ, et al. Treatment of anejaculation
with electroejaculation. Acta Urol Belg 1992;60:15–25.
85. Lucas MG, Hargreave TB, Edmond P, et al. Sperm retrieval
by electro-ejaculation. Preliminary experience in patients
with secondary anejaculation. Br J Urol 1991;67:191–194.
doi: 10.1111/j.1464-410x.1991.tb15108.x.
86. Chung PH, Palermo G, Schlegel PN, et al. The use of intracy-
toplasmic sperm injection with electroejaculates from aneja-
culatory men. Hum Reprod 1998;13:1854–1858. doi:
10.1093/humrep/13.7.1854.
87. Meng X, Fan L, Liu J, et al. Fresh semen quality in ejaculates
produced by nocturnal emission in men with idiopathic aneja-
culation. Fertil Steril 2013. doi: 10.1016/j.fertn-
stert.2013.07.1979.
88. Gat I, Maman E, Yerushalmi G, et al. Electroejaculation com-
bined with intracytoplasmic sperm injection in patients with
psychogenic anejaculation yields comparable results to
patients with spinal cord injuries. Fertil Steril 2012. doi:
10.1016/j.fertnstert.2012.01.129.
89. McGuire C, Manecksha RP, Sheils P, et al. Electroejacula-
tory stimulation for male infertility secondary to spinal
cord injury: The Irish experience in national rehabilitation
hospital. Urology 2011;77:83–87. doi: 10.1016/j.urol-
ogy.2010.07.477.
90. Ownsworth T, Chambers S, Damborg E, et al. Evaluation of
the making sense of brain tumor program: A randomized
controlled trial of a home-based psychosocial intervention.
Psychooncology 2015;24:540–547. doi: 10.1002/
pon.3687.
91. Das S, Dodd S, Soni BM, et al. Does repeated electro-ejacula-
tion improve sperm quality in spinal cord injured men? Spinal
Cord 2006;44:753–756. doi: 10.1038/sj.sc.3101898.Sex Med 2021;9:10037792. Hovav Y, Shotland Y, Yaffe H, et al. Electroejaculation and
assisted fertility in men with psychogenic anejaculation. Fer-
til Steril 1996;66:620–623. doi: 10.1016/S0015-0282(16)
58578-1.
93. Hovav Y, Sibirsky O, Pollack RN, et al. Comparison between
the first and the second electroejaculate qualities obtained
from neurologically intact men suffering from anejaculation.
Hum Reprod 2005;20:2620–2622. doi: 10.1093/humrep/
dei065.
94. Ohl DA, Wolf LJ, Menge AC, et al. Electroejaculation and
assisted reproductive technologies in the treatment of aneja-
culatory infertility. Fertil Steril 2001;76:1249–1255. doi:
10.1016/S0015-0282(01)02895-3.
95. Castle SM, Jenkins LC, Ibrahim E, et al. Safety and efficacy of
a new device for inducing ejaculation in men with spinal cord
injuries. Spinal Cord 2014;52:S27–S29. doi: 10.1038/
sc.2014.110.
96. Brackett NL, Ferrell SM, Aballa TC, et al. An analysis of 653
trials of penile vibratory stimulation in men with spinal cord
injury. J Urol 1998;159:1931–1934.
97. Sønksen J, Biering-Sørensen F, Kristensen JK. Ejaculation
induced by penile vibratory stimulation in men with spinal
cord injuries. The importance of the vibratory amplitude.
Paraplegia 1994;32:651–660. doi: 10.1038/sc.1994.105.
98. Meng X, Fan L, Liu J, et al. Fresh semen quality in ejaculates
produced by nocturnal emission in men with idiopathic aneja-
culation. Fertil Steril 2013;100:1248–1252. doi: 10.1016/j.
fertnstert.2013.07.1979.
99. Sønksen J, Ohl DA. Penile vibratory stimulation and
electroejaculation in the treatment of ejaculatory dys-
function. Int J Androl 2002. doi: 10.1046/j.1365-
2605.2002.00378.x.
100. Giannouli C, Goulis DG, Lambropoulos A, et al. Idiopathic
non-obstructive azoospermia or severe oligozoospermia: A
cross-sectional study in 61 Greek men. Int J Androl 2004.
doi: 10.1046/j.1365-2605.2003.00456.x.
101. Kruljac M, Finnbogadottir H, Bobjer J, et al. Symptoms of
sexual dysfunction among men from infertile couples: Preva-
lence and association with testosterone deficiency. Androl-
ogy 2019. doi: 10.1111/andr.12678.
102. van Zyl JA. Sex and infertility. Part I. Prevalence of psycho-
sexual problems and subjacent factors. S Afr Med J
1987;72:482–484.
103. Ramezanzadeh F, Aghssa MM, Jafarabadi M, et al. Altera-
tions of sexual desire and satisfaction in male partners of
infertile couples. Fertil Steril 2006. doi: 10.1016/j.fertn-
stert.2005.07.1285.
104. Bayar U, Basaran M, Atasoy N, et al. Sexual dysfunction in
infertile couples: Evaluation and treatment of infertility. J
Pak Med Assoc 2014;64:138–145.
105. Purcell-Levesque C, Brassard A, Carranza-Mamane B, et al.
Attachment and sexual functioning in women and men seek-
ing fertility treatment. J Psychosom Obstet Gynecol
2018:1–9. doi: 10.1080/0167482X.2018.1471462.
